Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telbivudine with TACE in HCC
NCT01102335Phase 4Unknown
- Sponsor
- Fudan University
- Start
- Apr 2010
- Primary completion
- Dec 2011
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of telbivudine in hepatitis B (HBV), sponsored by Fudan University. Status: unknown.
02
Drugs
telbivudine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT01102335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01102335.